Literature DB >> 18483128

Information on cost-effectiveness: an essential product of a national comparative effectiveness program.

.   

Abstract

The American College of Physicians recently highlighted the need to provide increased information comparing the effectiveness of health care interventions to ensure the rational and effective practice of medicine. Comparative effectiveness refers to the evaluation of the relative clinical effectiveness, safety, and cost of 2 or more medical services, drugs, devices, therapies, or procedures used to treat the same condition. The College further recommended the establishment of an adequately funded, trusted national entity that should prioritize, sponsor, or produce both comparative clinical and cost-effectiveness data. This article addresses the need for the proposed entity to develop cost-effectiveness information. It examines the current reluctance to develop and use cost-effectiveness in the United States; it argues for the importance of this information for all health care stakeholders; and it makes specific recommendations regarding how this information can best be made available and used for the good of the public and our patients.

Entities:  

Mesh:

Year:  2008        PMID: 18483128     DOI: 10.7326/0003-4819-148-12-200806170-00222

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  29 in total

1.  Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors.

Authors:  S M Cadarette; D H Solomon; J N Katz; A R Patrick; M A Brookhart
Journal:  Osteoporos Int       Date:  2010-06-08       Impact factor: 4.507

Review 2.  How should we use age to ration health care? Lessons from the case of kidney transplantation.

Authors:  Peter P Reese; Arthur L Caplan; Roy D Bloom; Peter L Abt; Jason H Karlawish
Journal:  J Am Geriatr Soc       Date:  2010-09-09       Impact factor: 5.562

3.  EBM, HTA, and CER: clearing the confusion.

Authors:  Bryan R Luce; Michael Drummond; Bengt Jönsson; Peter J Neumann; J Sanford Schwartz; Uwe Siebert; Sean D Sullivan
Journal:  Milbank Q       Date:  2010-06       Impact factor: 4.911

4.  Healthcare rationing by proxy: cost-effectiveness analysis and the misuse of the $50,000 threshold in the US.

Authors:  John F P Bridges; Eberechukwu Onukwugha; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

5.  Comparative effectiveness research and evidence-based health policy: experience from four countries.

Authors:  Kalipso Chalkidou; Sean Tunis; Ruth Lopert; Lise Rochaix; Peter T Sawicki; Mona Nasser; Bertrand Xerri
Journal:  Milbank Q       Date:  2009-06       Impact factor: 4.911

6.  Patient-reported outcomes of symptomatic cholelithiasis patients following cholecystectomy after at least 5 years of follow-up: a long-term prospective cohort study.

Authors:  Mark P Lamberts; Brenda L Den Oudsten; Frederik Keus; Jolanda De Vries; Cornelis J H M van Laarhoven; Gert P Westert; Joost P H Drenth; Jan A Roukema
Journal:  Surg Endosc       Date:  2014-06-21       Impact factor: 4.584

Review 7.  Cost effectiveness of fesoterodine and tolterodine for the treatment of overactive bladder with urge urinary incontinence in Spain and Finland.

Authors:  Javier C Angulo; Antti Valpas; Javier Rejas; Kari Linden; Marion Kvasz; Sonya J Snedecor
Journal:  Clin Drug Investig       Date:  2014-05       Impact factor: 2.859

8.  Comparative effectiveness research: the view from the NHLBI.

Authors:  Michael S Lauer
Journal:  J Am Coll Cardiol       Date:  2009-03-24       Impact factor: 24.094

9.  Recommendations for modeling disaster responses in public health and medicine: a position paper of the society for medical decision making.

Authors:  Margaret L Brandeau; Jessica H McCoy; Nathaniel Hupert; Jon-Erik Holty; Dena M Bravata
Journal:  Med Decis Making       Date:  2009-07-15       Impact factor: 2.583

10.  Comparative effectiveness and health care spending--implications for reform.

Authors:  Milton C Weinstein; Jonathan A Skinner
Journal:  N Engl J Med       Date:  2010-01-06       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.